Category Archive for News Germany
News Germany – Health system, AMNOG, price negotiations, legal framework and how to navigate these successfully
BPI calls for more spending on Germany’s outpatient sector
Dr. Kai Joachimsen, the Chief Executive of BPI – Der Bundesverband der Pharmazeutischen Industrie (Federal Association of the Pharmaceutical Industry) … read more »
G-BA to publish decisions in English as well as German
The German Federal Joint Committee will publish its early benefit assessments in English as well as German, following adoption of … read more »
Doctors in Germany to be able to prescribe mobile health applications
The German Government has recently adopted a law that will allow the prescription of mobile health applications with statutory health … read more »
Provocative IQWiG publication in BMJ challenges pharmaceutical innovation model
An article published in the British Medical Journal by IQWiG has argued that over half of new drugs entering the … read more »
BPI argue GSAV passed without sufficient challenge
The Bundesrat did not use its opportunity to challenge aspects of GSAV legislation when it approved it earlier this year, … read more »
BPI calls for end to price freeze
The German Preismoratorium has been challenged by the BPI as ineffective and without basis. The association of the German pharmaceutical … read more »
Germany to benefit from EU-US mutual recognition agreement for GMP inspections
Germany has been added to the list of EU member states able to approve GMP compliance within the mutual GMP … read more »
Germany and France sign MOSAR agreement
Germany and France have signed the MOSAR agreement which aims to increase patient access to healthcare services. Under the agreement, … read more »
Could the pay-for-performance model replace rebate negotiations?
Pay-for-performance deals could be replacing rebate negotiations for medicines hinted a GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) representative. … read more »
Amendments to the GSAV Bill: Vaccinations, Orphan drug registries, Biosimilars, ATMPs
The political parties CDU/CSU and SPD have agreed on significant changes on the GSAV Bill currently pending in the German … read more »
